Organic compounds

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 9/14 (2006.01) A61K 31/4015 (2006.01)

Patent

CA 2708083

A process for reducing the tendency of a drug substance to aggregate and/or agglomerate during storage. The process involves micronising the drug substance to give a mean particle size of less than about 10 µm, and exposing the micronised drug substance to a dry environment at an elevated temperature between 40° C and 120° C for at least six hours.

Le procédé de l'invention permet de réduire la tendance d'une substance médicamenteuse à s'agréger et/ou à s'agglomérer en stockage. Le procédé implique la micronisation de la substance médicamenteuse pour obtenir une taille de particules moyenne inférieure à environ 10 µm, et l'exposition de la substance médicamenteuse micronisée à un environnement sec à une température élevée comprise entre 40 et 120°C pendant au moins six heures.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1614737

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.